21 Comments
User's avatar
⭠ Return to thread
Donna Sudbrook's avatar

Yes, I think it will work.

These are my impressions from things I have read over the past 4 years since March 2020.

1. Dr. Hulda Clark ..... parasites and toxins are the source of all diseases/illness/cancer (can browse 2 of her books for free .... scroll down the page at this link to the "Download this book for FREE as a PDF" at this category Books at https://drclarkstore.com/collections/books/products/the-cure-for-all-diseases )

2. By definition .... viruses are obligate parasites (per Florida sharkman link to Brittanica dictionary?)

3. https://jeffreydachmd.com/2016/05/cancer-as-a-parasitic-disease/

4. apparently Dr. Paul Marik is the most published critical care physician in the world.... 200 page Cancer Care .... published in June 2023 ... updated periodically ... latest version at

https://covid19criticalcare.com/wp-content/uploads/2023/06/Cancer-Care-2024-03-29.pdf

he developed a protocol for sepsis which includes iv vitamin c, in 2016 .... used in 10% of U.S. hospitals I read in 2020 .... has a less than 1% mortality rate versus the 30-50% mortality rate of standard of care in the U.S. .... apparently 1000 a day?? or 200,000 to 300,000 Americans die of sepsis each year. https://www.faim.org/interview-with-dr-paul-marik-on-vitamin-c-protocol-for-sepsis

5. Dr. Judy Mikovits ... 3 books .... Plague, Plague of Corruption, End of Plague, retroviruses from cell lines used to produce vaccines are causing illness/disease/cancer throughout the population ..... her discoveries in 2009/2010 .... announced in 2011 I believe it was.

6. Dr. Robert Cathcart .... high enough divided doses of vitamin c will eliminate any virus

https://www.optimalc.com/images/xcathcart-vitamin-c-dose-chart.jpg.pagespeed.ic.9Q4ns_Xv02.jpg

https://www.losaltosonline.com/archives/obituary-robert-f-cathcart-iii-m-d-innovator-in-medicine/article_f03735f5-171c-5905-ad6d-9010b5bffc7f.html

7. www.orthomolecular.org select Library, select News Releases .... articles going back to 2005 ... very important information about advances in medical treatments using orthomolecular medicine from orthomolecular societies from around the world .....

first 10 minutes of this interview .... from Sept 2020 ...1000 doctors in Japan are using the Riordan protocol for cancer which includes IV vitamin C

https://www.youtube.com/watch?v=E7NoUcktt58

The Power of Intravenous Vitamin C with Dr Ron Hunninghake

Lisa Tamati Sep 18, 2020

Dr Ron Hunninghake is the Chief Medical Officer of the prestigious Riordan Institute in Witchita, Kansas.

In this episode Dr Ron explains the uses and mechanisms of action of Vitamin C both oral and intravenous Vitamin C and it's uses in cancer, sepsis, pneumonia, shingles, hepatitis to schizophrenia and mental illnesses.

They also discuss the problems facing functional medicine/orthomolecular medicine vs allopathic medicine and the pharmacological model dominant in our system today.

8. https://medicine.uiowa.edu/content/grant-will-fund-cancer-clinical-trials-test-high-dose-vitamin-c Grant will fund cancer clinical trials to test high-dose vitamin C

Date: Monday, November 19, 2018

Cancer researchers at University of Iowa Holden Comprehensive Cancer Center have received a five-year, $9.7 million grant from the National Cancer Institute to test the use of high-dose, intravenous (IV) vitamin C in the treatment of cancer.

The integrated project, led by Joseph Cullen, MD, UI professor of surgery, and Douglas Spitz, PhD, UI professor of radiation oncology, is designed to evaluate the feasibility and effectiveness of adding high-dose IV vitamin C to standard cancer treatments for three of the deadliest cancers affecting the U.S. population: pancreatic cancer, non-small cell lung cancer, and glioblastoma multiforme (GBM), an aggressive type of brain cancer.

“Success in this project would suggest that adding high-dose IV vitamin C to cancer treatment protocols could be a safe, simple, and cost-effective approach to improving treatment for many kinds of cancer,” Cullen says. “If the results from our early- and mid-phase clinical trials are positive, the next step would be to test this therapy in large, stage 3 clinical trials that could lead to approval of this approach and have a powerful and lasting impact on clinical cancer care in the coming years.”

Expand full comment
ErrorError